Dr. Naureckas’ research involves care delivery of appropriate care for diseases of the airways specifically cystic fibrosis, bronchiectasis, asthma and COPD. He participates as a principal investigator or co-investigator in multicenter research networks focused on cystic fibrosis, asthma and COPD. These include the American Lung Association Asthma Clinical Research Consortium, and the NIH sponsored PrecISE Network. He also serves as local PI on trials conducted by the Cystic Fibrosis Foundation sponsored Therapeutics Development Network. He also servChairman of the Cystic Fibrosis Foundation's Guidelines Steering Committee.
University of Chicago
Chicago, IL
- Pulmonary/CC
1994
Michael Reese Hospital
Chicago, IL
- Medicine
1991
Washington University in St. Louis
St. Louis, Mo
MD
1987
Marquette University
Milwaukee
BS - Biomedical Engineering
1983
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients.
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients. Am J Respir Crit Care Med. 2024 07 01; 210(1):108-118.
PMID: 38668710
Multi-omics in nasal epithelium reveals three axes of dysregulation for asthma risk in the African Diaspora populations.
Multi-omics in nasal epithelium reveals three axes of dysregulation for asthma risk in the African Diaspora populations. Nat Commun. 2024 May 28; 15(1):4546.
PMID: 38806494
Discerning asthma endotypes through comorbidity mapping.
Discerning asthma endotypes through comorbidity mapping. Nat Commun. 2022 11 07; 13(1):6712.
PMID: 36344522
DNA methylation signatures in airway cells from adult children of asthmatic mothers reflect subtypes of severe asthma.
DNA methylation signatures in airway cells from adult children of asthmatic mothers reflect subtypes of severe asthma. Proc Natl Acad Sci U S A. 2022 06 14; 119(24):e2116467119.
PMID: 35666868
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations. Int Forum Allergy Rhinol. 2022 09; 12(9):1089-1103.
PMID: 35089650
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma.
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. Lancet Child Adolesc Health. 2021 12; 5(12):862-872.
PMID: 34762840
Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region.
Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region. Nat Commun. 2021 10 21; 12(1):6115.
PMID: 34675193
A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma. Eur Respir J. 2021 07; 58(1).
PMID: 33446603
Geography, generalisability, and susceptibility in clinical trials.
Geography, generalisability, and susceptibility in clinical trials. Lancet Respir Med. 2021 04; 9(4):330-332.
PMID: 33539731
Patient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience.
Patient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience. J Particip Med. 2020 Jul 13; 12(3):e17875.
PMID: 33064090